{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:38:18Z","timestamp":1790678298719,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T00:00:00Z","timestamp":1416441600000},"content-version":"vor","delay-in-days":415,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002997","name":"Dutch Kidney Foundation","doi-asserted-by":"crossref","award":["IK08.03"],"award-info":[{"award-number":["IK08.03"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"crossref"}]},{"name":"EURYI award"},{"DOI":"10.13039\/501100000782","name":"European Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000782","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.bbadis.2013.05.002","type":"journal-article","created":{"date-parts":[[2013,5,9]],"date-time":"2013-05-09T09:15:25Z","timestamp":1368090925000},"page":"1715-1722","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Hyperuricemia influences tryptophan metabolism via inhibition of multidrug resistance protein 4 (MRP4) and breast cancer resistance protein (BCRP)"],"prefix":"10.1016","volume":"1832","author":[{"given":"Anita C.A.","family":"Dankers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henricus A.M.","family":"Mutsaers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry B.P.M.","family":"Dijkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lambertus P.","family":"van den Heuvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost G.","family":"Hoenderop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred C.G.J.","family":"Sweep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans G.M.","family":"Russel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalinde","family":"Masereeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2013.05.002_bb0005","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2147\/VHRM.S4265","article-title":"Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress","volume":"5","author":"George","year":"2009","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0010","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/hr.2011.39","article-title":"Oxidative stress and endothelial dysfunction in hypertension","volume":"34","author":"Schulz","year":"2011","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0015","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.2174\/138161205774913255","article-title":"Uric acid and oxidative stress","volume":"11","author":"Glantzounis","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0020","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/ndt\/gfr530","article-title":"Serum uric acid and chronic kidney disease: the Severance cohort study","volume":"27","author":"Mok","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0235","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physiol.00039.2004","article-title":"Molecular physiology of urate transport","volume":"20","author":"Hediger","year":"2005","journal-title":"Physiology (Bethesda)"},{"issue":"Suppl. 1","key":"10.1016\/j.bbadis.2013.05.002_bb0030","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar1907","article-title":"Epidemiology, risk factors, and lifestyle modifications for gout","volume":"8","author":"Saag","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0035","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0149-2918(03)80158-3","article-title":"A literature review of the epidemiology and treatment of acute gout","volume":"25","author":"Kim","year":"2003","journal-title":"Clin. Ther."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0040","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1053\/j.jrn.2010.10.015","article-title":"Metabolic syndrome and the genesis of uric acid stones","volume":"21","author":"Maalouf","year":"2011","journal-title":"J. Ren. Nutr."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0045","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Feig","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0050","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2337\/dc07-1276","article-title":"High serum uric acid as a novel risk factor for type 2 diabetes","volume":"31","author":"Dehghan","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbadis.2013.05.002_bb0055","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1681\/ASN.2006080865","article-title":"Plasma uric acid level and risk for incident hypertension among men","volume":"18","author":"Forman","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0060","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11906-006-0005-z","article-title":"Uric acid and hypertension","volume":"8","author":"Feig","year":"2006","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0065","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/j.1523-1755.2005.00273.x","article-title":"Hyperuricemia induces endothelial dysfunction","volume":"67","author":"Khosla","year":"2005","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.bbadis.2013.05.002_bb0240","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1681\/ASN.2008101115","article-title":"Posing the question again: does chronic uric acid nephropathy exist?","volume":"21","author":"Moe","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0075","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pharmthera.2010.05.006","article-title":"Common pathophysiological mechanisms of chronic kidney disease: therapeutic perspectives","volume":"128","author":"Lopez-Novoa","year":"2010","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.bbadis.2013.05.002_bb0245","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1093\/ndt\/gfr597","article-title":"The association between plasma uric acid and renal function decline in a Chinese population-based cohort","volume":"27","author":"Zhang","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0085","first-page":"3","article-title":"Gout and hyperuricemia","volume":"36","author":"Chilappa","year":"2010","journal-title":"Compr. Ther."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0090","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0021-9258(18)56639-4","article-title":"The metabolism of uric acid in the normal and gouty human studied with the aid of isotopic uric acid","volume":"181","author":"Benedict","year":"1949","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0095","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ng.106","article-title":"SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout","volume":"40","author":"Vitart","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0100","doi-asserted-by":"crossref","first-page":"F327","DOI":"10.1152\/ajprenal.00133.2004","article-title":"Human organic anion transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate with multiple allosteric substrate binding sites","volume":"288","author":"van Aubel","year":"2005","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0250","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000237","article-title":"Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population","volume":"1","author":"Matsuo","year":"2009","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0110","doi-asserted-by":"crossref","first-page":"10338","DOI":"10.1073\/pnas.0901249106","article-title":"Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout","volume":"106","author":"Woodward","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0115","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/BOR.0b013e328032781a","article-title":"New insights into renal transport of urate","volume":"19","author":"Anzai","year":"2007","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0120","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/ncomms1756","article-title":"Decreased extra-renal urate excretion is a common cause of hyperuricemia","volume":"3","author":"Ichida","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0125","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1016\/j.cca.2011.07.031","article-title":"A metabolic profiling analysis of symptomatic gout in human serum and urine using high performance liquid chromatography-diode array detector technique","volume":"412","author":"Liu","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbadis.2013.05.002_bb0130","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1039\/c2mb25227a","article-title":"Metabolite target analysis of human urine combined with pattern recognition techniques for the study of symptomatic gout","volume":"8","author":"Liu","year":"2012","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0135","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1208\/s12248-012-9404-z","article-title":"Regulatory pathways for ATP-binding cassette transport proteins in kidney proximal tubules","volume":"14","author":"Masereeuw","year":"2012","journal-title":"AAPS J."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0140","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1124\/jpet.106.110379","article-title":"Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2\/ABCC2- and MRP4\/ABCC4-mediated methotrexate transport","volume":"320","author":"El-Sheikh","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0145","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00441-012-1417-5","article-title":"Localization of breast cancer resistance protein (Bcrp) in endocrine organs and inhibition of its transport activity by steroid hormones","volume":"349","author":"Dankers","year":"2012","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0150","doi-asserted-by":"crossref","first-page":"e18438","DOI":"10.1371\/journal.pone.0018438","article-title":"Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations","volume":"6","author":"Mutsaers","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2013.05.002_bb0155","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1124\/dmd.110.037812","article-title":"Cannabinoid type 1 receptor antagonists modulate transport activity of multidrug resistance-associated proteins MRP1, MRP2, MRP3, and MRP4","volume":"39","author":"Wittgen","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0160","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1681\/ASN.2006070759","article-title":"Uric acid heralds ischemic tissue injury to mobilize endothelial progenitor cells","volume":"18","author":"Patschan","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0165","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nrd3793","article-title":"Kynurenines in the CNS: recent advances and new questions","volume":"12","author":"Vecsei","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0170","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nrd870","article-title":"Endogenous kynurenines as targets for drug discovery and development","volume":"1","author":"Stone","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0175","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF02590750","article-title":"Inhibition by kynurenine metabolites of proinsulin synthesis in isolated pancreatic islets","volume":"15","author":"Noto","year":"1978","journal-title":"Acta Diabetol. Lat."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0180","first-page":"227","article-title":"Effect of quinaldic acid and its relatives on insulin-release from isolated Langerhans islets","volume":"29","author":"Okamoto","year":"1975","journal-title":"Acta Vitaminol. Enzymol."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0185","first-page":"755","article-title":"Kynurenine and its metabolites in the rat with experimental renal insufficiency","volume":"52","author":"Pawlak","year":"2001","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0190","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2478\/v10039-010-0015-6","article-title":"Kynurenine pathway\u2014a new link between endothelial dysfunction and carotid atherosclerosis in chronic kidney disease patients","volume":"55","author":"Pawlak","year":"2010","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0195","doi-asserted-by":"crossref","first-page":"19189","DOI":"10.1074\/jbc.M109.024042","article-title":"Kynurenic acid triggers firm arrest of leukocytes to vascular endothelium under flow conditions","volume":"284","author":"Barth","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0200","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bbadis.2012.09.006","article-title":"Uremic toxins inhibit renal metabolic capacity through interference with glucuronidation and mitochondrial respiration","volume":"1832","author":"Mutsaers","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.bbadis.2013.05.002_bb0255","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.it.2012.10.001","article-title":"Indoleamine 2,3 dioxygenase and metabolic control of immune responses","volume":"34","author":"Munn","year":"2013","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0210","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature10491","article-title":"An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor","volume":"478","author":"Opitz","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2013.05.002_bb0215","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1021\/bi901786x","article-title":"The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor","volume":"49","author":"Schroeder","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2013.05.002_bb0220","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1253\/circj.CJ-12-0647","article-title":"Activation of aryl hydrocarbon receptor mediates indoxyl sulfate-induced monocyte chemoattractant protein-1 expression in human umbilical vein endothelial cells","volume":"77","author":"Watanabe","year":"2012","journal-title":"Circ. J."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0225","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/ng.107","article-title":"SLC2A9 influences uric acid concentrations with pronounced sex-specific effects","volume":"40","author":"Doring","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0230","doi-asserted-by":"crossref","first-page":"e1000504","DOI":"10.1371\/journal.pgen.1000504","article-title":"Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations","volume":"5","author":"Kolz","year":"2009","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbadis.2013.05.002_bb0260","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/ng.2500","article-title":"Genome-wide association analyses identify 18 new loci associated with serum urate concentrations","volume":"45","author":"Kottgen","year":"2013","journal-title":"Nat. Genet."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443913001567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443913001567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T11:17:14Z","timestamp":1645010234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443913001567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0925443913001567"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2013.05.002","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperuricemia influences tryptophan metabolism via inhibition of multidrug resistance protein 4 (MRP4) and breast cancer resistance protein (BCRP)","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2013.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}